FDA Approves Glenmark's Generic Nausea Tablets
Posted on: Tuesday, 19 September 2006, 12:01 CDT
Indian company Glenmark Pharmaceuticals has received FDA approval for ondansetron hydrochloride tablets that treat nausea and vomiting.
Ondansetron tablets are the generic version of GlaxoSmithKline's Zofram tablets. Zofram belongs to a class of antiemetics that treat nausea caused by cancer chemotherapy, radiation therapy, anesthesia, and surgery. According to Glenmark, Zofram had annual sales of $640 million last year. Zofram can be administered by injection or tablets.
Glenmark Pharmaceuticals has generic formulations and API interest in over 80 countries including the US and Europe. The company is engaged in discovery projects in the areas of inflammation and metabolic disorders.
Source: Datamonitor
Related Articles
- FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets
- Glenmark Generics Launches Trandolapril Tablets
- Glenmark Launches Arthritis and Anxiety Drugs in US Market
- Glenmark Cleared By FDA to Market Generic Pravachol
- (COR.TO) Corel Grafigo Wins 'Best of Show' Award; Industry Acclaim and Extensive User Up-Take Support Tablet PC Graphics Tool
- GiveMePower Ships New PowerCAD Pro For Windows Desktop, Laptop And XP Tablet PCs
- Leszynski Group Launches Training Products for Tablet PC Solution Developers
- NEC Versa LitePad Tablet PC Wins 2003 World Class Award from PC World
- Itronix's tablet PC gets rugged
 |
 |
User Comments (0)
RSS Feeds